TOP STORIES

• BUSINESS Generic Shipment Price Rate Likely Rose 1.5% for FY2023 Revision, Weighing on Wholesalers
  April 10, 2023

• REGULATORY 9-Valent HPV Vaccine Program Poses Opportunity to Boost Inoculation Rate: LDP Lawmaker
  April 7, 2023

• BUSINESS MSD Japan Nets 24% Growth in 2022 on Lagevrio, Keytruda; President Wary of Further Re-Pricing
  April 6, 2023

• REGULATORY Expert Panel Mixed on Macroeconomic Indexing of Drug Cost; Govt Urged to Quit Targeting Pharma for Savings
  April 5, 2023

• BUSINESS 19 of 41 Drug Makers Log P/B Ratio Below 1; TSE’s Quest to Boost Market Cap Not Easy
  April 4, 2023

• COMMENTARY Some Pharma Makers Leery of Further Cut into Off-Patent Brands in Japan
  April 3, 2023

• BUSINESS Merck Poised to Work Together with Japan towards 90% HPV Vaccine Rate: Exec
  March 31, 2023

• ACADEMIA Obesity Med Wegovy Could Be “Ace in the Hole”, Should Avoid Fate of Oblean: KOL
  March 30, 2023

• REGULATORY Audit Questions Rationale for Order of 882 Million COVID Vaccine Doses
  March 30, 2023

• REGULATORY Japan’s Foreign Minister Likely to Visit China Soon, Demand Citizen’s Release
  March 29, 2023

• REGULATORY Japan Approves Wegovy, Omvoh, FluMist, Entyvio SC and More
  March 28, 2023

• BUSINESS Novartis Japan Sees 2023 OK for 1st siRNA Drug for Hyperlipidemia, 7 Approvals to Drive Growth
  March 27, 2023

• ORGANIZATION Japan Umbrella Trade Organ to Beef Up Functions for Lobbying Activity
  March 24, 2023

• REGULATORY Generic Dispensing Tops 82%; 57% of Pharmacies Not Active on Biosimilars: Poll
  March 23, 2023

• REGULATORY MHLW Council Discusses Root Causes of Drug Supply Disruptions, Yakkasa Issues
  March 22, 2023

• REGULATORY Expert Panel Talks over Yakkasa, Revamp of Price Revision Method; Fixed Margin, Claw-Back Mooted
  March 20, 2023

• BUSINESS CSL R&D Head Touts Cost-Effectiveness of Hemophilia Gene Therapy Hemgenix
  March 17, 2023

• BUSINESS Illumina Eyes Japan Launch of Comprehensive Genomic Profiling Test This Year
  March 16, 2023

• BUSINESS Teijin Pharma Plans Pivot to Rare Diseases as Generics Eat into Feburic Sales
  March 15, 2023

• BUSINESS Eisai’s Leqembi Wins Coverage from US Veteran’s Body
  March 15, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 52
• 53
• 54
• 55
• 56
• 57
• 58
• 59
• 60
• …
• Next ›
• 最終 »